John G Ullman & Associates Inc. Sells 700 Shares of Azenta, Inc. (NASDAQ:AZTA)

John G Ullman & Associates Inc. reduced its stake in Azenta, Inc. (NASDAQ:AZTA) by 0.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 79,793 shares of the company’s stock after selling 700 shares during the quarter. John G Ullman & Associates Inc. owned about 0.16% of Azenta worth $3,865,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Hantz Financial Services Inc. bought a new stake in shares of Azenta in the 2nd quarter valued at $30,000. Farther Finance Advisors LLC grew its holdings in Azenta by 20.0% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,537 shares of the company’s stock worth $74,000 after acquiring an additional 256 shares during the period. Benjamin F. Edwards & Company Inc. raised its position in shares of Azenta by 150.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 1,588 shares of the company’s stock worth $84,000 after acquiring an additional 955 shares in the last quarter. Lazard Asset Management LLC acquired a new position in shares of Azenta in the 1st quarter valued at about $130,000. Finally, Acadian Asset Management LLC boosted its position in shares of Azenta by 24.7% during the 1st quarter. Acadian Asset Management LLC now owns 2,381 shares of the company’s stock valued at $143,000 after purchasing an additional 471 shares in the last quarter. 99.08% of the stock is currently owned by institutional investors.

Azenta Stock Up 9.1 %

Shares of Azenta stock opened at $44.65 on Thursday. The business has a 50-day simple moving average of $45.32 and a 200 day simple moving average of $50.22. Azenta, Inc. has a one year low of $38.82 and a one year high of $69.16.

Azenta (NASDAQ:AZTA) last issued its earnings results on Tuesday, November 12th. The company reported $0.18 earnings per share for the quarter, topping analysts’ consensus estimates of $0.10 by $0.08. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%. The company had revenue of $170.00 million for the quarter, compared to analyst estimates of $169.66 million. During the same period in the prior year, the firm earned $0.13 earnings per share. Azenta’s revenue for the quarter was down 1.2% on a year-over-year basis. Research analysts anticipate that Azenta, Inc. will post 0.4 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on AZTA shares. Needham & Company LLC lowered their target price on Azenta from $69.00 to $55.00 and set a “buy” rating for the company in a report on Wednesday, November 13th. Evercore ISI lowered their price objective on shares of Azenta from $53.00 to $50.00 and set an “in-line” rating for the company in a research note on Tuesday, October 1st. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $63.60.

Insider Buying and Selling at Azenta

In related news, CEO John Marotta acquired 12,717 shares of the company’s stock in a transaction on Monday, November 18th. The shares were acquired at an average cost of $39.48 per share, for a total transaction of $502,067.16. Following the purchase, the chief executive officer now owns 99,612 shares in the company, valued at approximately $3,932,681.76. The trade was a 14.63 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director William L. Cornog bought 12,500 shares of Azenta stock in a transaction dated Monday, November 18th. The stock was purchased at an average price of $39.60 per share, with a total value of $495,000.00. Following the purchase, the director now owns 14,755 shares in the company, valued at approximately $584,298. This represents a 554.32 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 1.77% of the company’s stock.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.